Reading the adjunct evidence the way a reviewer would The pivotal liraglutide trials, ADJUNCT ONE and TWO, showed HbA1c effects below the regulatory threshold alongside dose-related ketosis and symptomatic hypoglycaemia, and the FDA did not approve liraglutide for type 1 on efficacy and safety grounds.6 The newer story is the automated-insulin-delivery era: ADJUST-T1D paired weekly semaglutide with an AID system in 72 adults with type 1 and obesity, and a composite goal (time in range above 70%, time below range under 4%, and at least 5% weight loss) was met by 36% versus 0% on placebo, with no ketoacidosis.8 Tirzepatide in type 1 rests on a single-centre observational cohort of 26 with no control arm
Treatment for overweight and obesity
If youd like to give yerba mate a try, start slowly and make sure to let it cool a little before drinking it.
I've gotten both Botox and lip filler, and my results look so natural and exactly what I wanted
But beneath the buzz lies a fascinating piece of biology
Start with one month at $300, or commit to a full three-month protocol at $810 and save